Dual‐Targeted, pH/Reduction‐Responsive Mesoporous Silica Nanocarriers for Selective Sorafenib Delivery to Hepatocellular Carcinoma

Advanced Therapeutics · Published 2026-07-29 · DOI 10.1002/adtp.202500581

Authors (9)

Sahra Perseh, Reza Bafkary, Hossein Salmani, Mohammad Hassan Shahriari, Rassoul Dinarvand, Ismaeil Haririan, Seyedeh Sahar Mojtabazadeh, Sanaz Jamshidfar, Mohammad Akrami

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Perseh, S., Bafkary, R., Salmani, H., et al. (2026). Dual‐Targeted, pH/Reduction‐Responsive Mesoporous Silica Nanocarriers for Selective Sorafenib Delivery to Hepatocellular Carcinoma. Advanced Therapeutics. https://doi.org/10.1002/adtp.202500581

Related articles

• Light‐Triggered Antibody‐Photosensitizer Conjugates Disrupt P‐Glycoprotein Function to Reverse Multidrug Resistance · Advanced Therapeutics · 2026 · Same journal
• Formulation and Characterization of Doxorubicin Loaded N‐acetyl Neuraminic Acid Coupled Biodegradable Nanoparticles for Lung Cancer Treatment: In Vitro and In Vivo Assessment · Advanced Therapeutics · 2026 · Same journal
• Indirubin‐Loaded CuS Nanoparticles: A Metallo‐Alkaloidal Theranostic Platform for Colorectal Cancer · Advanced Therapeutics · 2025 · Same journal
• Injectable Self‐Healing Quaternized Chitosan/Oxidized Pectin Hydrogels for Targeted siRNA Nanoparticle Delivery in Breast Cancer Therapy · Advanced Therapeutics · 2026 · Same journal
• Intra‐Articular Injectable Chitosan‐PVA Hydrogel Ingrained With Gallic Acid Loaded Mesoporous Silica Nanoparticles for Pain Relief and Cartilage Regeneration in Obese Osteoarthritic Rats · Advanced Therapeutics · 2026 · Same journal
• Cover Feature: Structural Characterization and AI‐Enhanced Modeling of a Broadly Neutralizing Camelid Antibody Against SARS‐CoV‐2 Variants (Adv. Therap. 1/2026) · Advanced Therapeutics · 2026 · Same journal
• Extracellular Vesicles: Biology, Intercellular Communication and Therapeutic Potential in Diabetes · Advanced Therapeutics · 2026 · Same journal
• Microneedle‐Assisted Systems for the Delivery of Proteolysis Targeting Chimeras (PROTACs) · Advanced Therapeutics · 2026 · Same journal
• Nanotechnology‐Enhanced Stemcell Therapy for Precision Regeneration Medicine: Mechanistic Advances, Engineering Strategies, and Clinical Translation · Advanced Therapeutics · 2026 · Same journal
• Targeting Ferroptosis for Cancer Immunotherapy: Molecular Mechanisms, Immune Microenvironment Crosstalk, and Clinical Translation Prospects · Advanced Therapeutics · 2026 · Same journal